BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10722505)

  • 1. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
    Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
    Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia.
    Azoulay-Dupuis E; Bédos JP; Mohler J; Schmitt-Hoffmann A; Schleimer M; Shapiro S
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1105-11. PubMed ID: 15047508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
    Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia.
    Wang E; Bergeron Y; Bergeron MG
    J Antimicrob Chemother; 2005 May; 55(5):721-6. PubMed ID: 15772139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
    Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of tedizolid phosphate (TR-701) in murine models of infection with penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae.
    Choi S; Im W; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4713-7. PubMed ID: 22713339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    Barry B; Muffat-Joly M; Bauchet J; Faurisson F; Gehanno P; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1977-82. PubMed ID: 8878566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia.
    Gentry-Nielsen MJ; Olsen KM; Preheim LC
    Antimicrob Agents Chemother; 2002 May; 46(5):1345-51. PubMed ID: 11959567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Mohler J; Bédos JP
    Antimicrob Agents Chemother; 2004 Jan; 48(1):80-5. PubMed ID: 14693522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.
    Steed ME; Vidaillac C; Winterfield P; Biek D; Rybak MJ
    Antimicrob Agents Chemother; 2012 May; 56(5):2691-5. PubMed ID: 22354289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
    Tan TQ; Mason EO; Barson WJ; Wald ER; Schutze GE; Bradley JS; Arditi M; Givner LB; Yogev R; Kim KS; Kaplan SL
    Pediatrics; 1998 Dec; 102(6):1369-75. PubMed ID: 9832571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology analysis of 51 penicillin-intermediate
    Zhang J; Hu DK; Gao CY; Shen WW; Luo XH; Yu J; Li XY; Jiang XY; Zhu WS; Chen WQ
    J Int Med Res; 2020 Jun; 48(6):300060520919061. PubMed ID: 32529912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.